News related to Dilantin-125 (Phenytoin) and/or conditions it is approved for
FDA Warns of Skin Reactions from Phenytoin Use in Patients with HLA Allele Source: MedPage Today Product Alert [2008.11.24] ROCKVILLE, Md. (MedPage Today) -- Using the antiepileptic drug phenytoin (Dilantin, Phenytek) to treat Asian patients with a particular human leukocyte antigen allele could increase the risk of serious skin reactions, according to the FDA.